Recursion Pharmaceuticals
clinical single center double blind placebo controlled dose study in healthy volunteers accomplished further confidence data generated by recursion | Recursion Pharmaceuticals
Company
Deck Type
Sector
Industry
Deck date
January 2023
Slide
111 of 143
Related slides by other companies
Arbutus Biopharma
Investor Presentation
January 2024
phase a clinical trial | Arbutus Biopharma
Arbutus Biopharma
Investor Presentation
November 2023
phase a clinical trial a placebo weeks will be presented at | Arbutus Biopharma
NeuroSense Therapeutics
Investor Presentation
January 2024
phase trial design randomized prospective double blind placebo controlled study sees | NeuroSense Therapeutics
NeuroSense Therapeutics
Investor Presentation
December 2023
phase trial design randomized prospective double blind placebo controlled study | NeuroSense Therapeutics
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io